{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:07:16Z","timestamp":1789726036296,"version":"4.0.1"},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Women with HIV face a higher risk of cervical cancer. This review synthesizes evidence on precancerous cervical lesions among women with HIV in sub-Saharan Africa (SSA), regional differences, risk factors, and approaches to integrating cervical cancer prevention into HIV services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a comprehensive literature search across PubMed, Embase, Scopus, and Web of Science databases through December 2025 and identified studies evaluating the prevalence of precancerous cervical lesions among women with HIV in SSA. It highlights prevalence, ongoing global efforts, and integration strategies specific to SSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of precancerous cervical lesions among women with HIV in SSA is higher in Tanzania (71.8%), and Kenya (42%), eastern countries than from western (Nigeria, 26.6%) or southern countries (South Africa, 23.2%), influenced by the distribution of human papillomavirus (HPV) genotypes, including higher-risk HPV (HR-HPV) such as HPV 35, which is not targeted by the HPV vaccine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Given the increased risk among women with HIV and the substantial burden in SSA, evidence suggests that integrating HPV-based cervical cancer screening and vaccination into HIV care platforms could help close the prevention gap and reduce the dual burden among women with HIV in SSA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag509","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:37:15Z","timestamp":1786448235000},"source":"Crossref","is-referenced-by-count":0,"title":["Integrating Cervical Cancer Prevention into HIV Services in Sub-Saharan Africa: A Narrative Review Addressing the Dual Burden Among Women"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2058-3305","authenticated-orcid":false,"given":"Essa","family":"Ceesay","sequence":"first","affiliation":[{"name":"National Cancer Control Program, Ministry of Health , Banjul ,","place":["The Gambia"]},{"name":"Department of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital , Harbin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5232-0645","authenticated-orcid":false,"given":"Juval","family":"Avala Ntsigouaye","sequence":"additional","affiliation":[{"name":"Oncology Group, Global Organization of African Academic Doctors , Langata, Nairobi ,","place":["Kenya"]},{"name":"Faculty of Medicine, Marien Ngouabi University , Brazzaville ,","place":["Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4236-1758","authenticated-orcid":false,"given":"Justina Ucheojor","family":"Onwuka","sequence":"additional","affiliation":[{"name":"Genomic Epidemiology Branch, International Agency for Research on Cancer , Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shanshan","sequence":"additional","affiliation":[{"name":"Department of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital , Harbin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4673-2998","authenticated-orcid":false,"given":"Itunu Olufunke","family":"Sokale","sequence":"additional","affiliation":[{"name":"Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radheshyam","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Urology Surgery, Third Affiliated Hospital of Harbin Medical University , Harbin ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-0926","authenticated-orcid":false,"given":"Marvellous","family":"Okeke","sequence":"additional","affiliation":[{"name":"Oncology Group, Global Organization of African Academic Doctors , Langata, Nairobi ,","place":["Kenya"]},{"name":"Department of Oncology, School of Medicine, Southeast University , Nanjing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evissi-Kouva","family":"Okiemy","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Marien Ngouabi University , Brazzaville ,","place":["Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2674-2892","authenticated-orcid":false,"given":"Kebba S","family":"Bojang","sequence":"additional","affiliation":[{"name":"National Cancer Control Program, Ministry of Health , Banjul ,","place":["The Gambia"]},{"name":"School of Medicine and Allied Health Sciences, University of The Gambia , Banjul ,","place":["The Gambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Belec","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie, H\u00f4pital Europ\u00e9en Georges Pompidou, Assistance Publique-H\u00f4pitaux de Paris (AP-HP) and Universit\u00e9 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"2026091805314982700_ofag509-B1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ijc.34707","article-title":"Cervical precancer and cancer incidence among insured women with and without HIV in South Africa","volume":"154","author":"Villalobos","year":"2024","journal-title":"Int J Cancer"},{"key":"2026091805314982700_ofag509-B2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ijc.33841","article-title":"Age-specific burden of cervical cancer associated with HIV: a global analysis with a focus on sub-Saharan Africa","volume":"150","author":"Khalil","year":"2022","journal-title":"Int J Cancer"},{"key":"2026091805314982700_ofag509-B3","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2026091805314982700_ofag509-B4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ijgc-2022-003957","article-title":"Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services","volume":"33","author":"Dzinamarira","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"2026091805314982700_ofag509-B5","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026091805314982700_ofag509-B6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1470-2045(20)30729-4","article-title":"WHO launches strategy to accelerate elimination of cervical cancer","volume":"22","author":"Das","year":"2021","journal-title":"Lancet Oncol"},{"key":"2026091805314982700_ofag509-B7","doi-asserted-by":"crossref","DOI":"10.1186\/s12978-026-02274-4","article-title":"Impact of the 2013 WHO guidelines for screening and treatment of cervical pre-cancerous lesions on women's screening uptake, by HIV-status, in Eastern and Southern Africa: a regression discontinuity design analysis","volume":"23","author":"Chipanta","year":"2026","journal-title":"Reprod Health"},{"key":"2026091805314982700_ofag509-B8","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12081032","article-title":"Variability of high-risk human papillomavirus and associated factors among women in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"12","author":"Tchouaket","year":"2023","journal-title":"Pathogens"},{"key":"2026091805314982700_ofag509-B9","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2021039","article-title":"Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: a 20-year systematic review","volume":"43","author":"Okoye","year":"2021","journal-title":"Epidemiol Health"},{"key":"2026091805314982700_ofag509-B10","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.890880","article-title":"Prevalence and genotype distribution of high-risk human papillomavirus infection among Sub-Saharan African women: a systematic review and meta-analysis","volume":"10","author":"Seyoum","year":"2022","journal-title":"Front Public Health"},{"key":"2026091805314982700_ofag509-B11","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"key":"2026091805314982700_ofag509-B12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301997","article-title":"Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: a modeling analysis","volume":"19","author":"Broshkevitch","year":"2024","journal-title":"PLoS One"},{"key":"2026091805314982700_ofag509-B13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1200\/JGO.2015.002964","article-title":"Influence of HIV\/AIDS on cervical cancer: a retrospective study from Tanzania","volume":"3","author":"Chambuso","year":"2017","journal-title":"J Glob Oncol"},{"key":"2026091805314982700_ofag509-B14","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2021.39.44.27182","article-title":"Prevalence and correlates of cervical squamous intraepithelial lesions among HIV-infected and uninfected women in Central Kenya","volume":"39","author":"Njagi","year":"2021","journal-title":"Pan Afr Med J"},{"key":"2026091805314982700_ofag509-B15","article-title":"The association between HIV infection and cervical cancer presentation and survival in Uganda","volume":"31","author":"Wu","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"2026091805314982700_ofag509-B16","first-page":"719","article-title":"Prevalence and determinants of pre-cancerous cervical lesion and human papillomavirus among HIV-infected and HIV-uninfected women in North\u2013West Ethiopia: a comparative retrospective cross-sectional study","volume":"13","author":"Kiros","year":"2021","journal-title":"HIV AIDS (Auckl)"},{"key":"2026091805314982700_ofag509-B17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.910915","article-title":"Precancerous cervical lesion among adult women with human immune deficiency virus on anti retroviral therapy at Saint Peter Specialized Hospital, Ethiopia: a hospital-based cross-sectional study","volume":"12","author":"Zelalem","year":"2022","journal-title":"Front Oncol"},{"key":"2026091805314982700_ofag509-B18","first-page":"308","article-title":"Cervical cytology among HIV positive and HIV negative women in a tertiary hospital in North Central Nigeria: a comparative study","volume":"7","author":"Ishak Lawal","year":"2017","journal-title":"Ann Med Health Sci Res"},{"key":"2026091805314982700_ofag509-B19","article-title":"Human papillomavirus correlates of high grade cervical dysplasia among HIV-infected women at a major treatment centre in Nigeria: a cross-sectional study","volume":"33","author":"Yakub","year":"2019","journal-title":"Pan Afr Med J"},{"key":"2026091805314982700_ofag509-B20","doi-asserted-by":"crossref","DOI":"10.1177\/11795549241234620","article-title":"Factors associated with precancerous cervical lesions in human immunodeficiency virus-infected women: a cross-sectional survey in Togo","volume":"18","author":"Darr\u00e9","year":"2024","journal-title":"Clin Med Insights Oncol"},{"key":"2026091805314982700_ofag509-B21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/bjc.2012.299","article-title":"Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Cote d'Ivoire, 2010","volume":"107","author":"Jaquet","year":"2012","journal-title":"Br J Cancer"},{"key":"2026091805314982700_ofag509-B22","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-017-4120-3","article-title":"Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland","volume":"17","author":"Jolly","year":"2017","journal-title":"BMC Public Health"},{"key":"2026091805314982700_ofag509-B23","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-016-3530-y","article-title":"Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study","volume":"16","author":"Msyamboza","year":"2016","journal-title":"BMC Public Health"},{"key":"2026091805314982700_ofag509-B24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4102\/phcfm.v12i1.2215","article-title":"Abnormal cervical cytology amongst women infected with human immunodeficiency virus in Limpopo province, South Africa","volume":"12","author":"Ntuli","year":"2020","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"2026091805314982700_ofag509-B25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/QAI.0b013e3182426227","article-title":"Cervical cancer prevention in HIV-infected women using the \u201csee and treat\u201d approach in Botswana","volume":"59","author":"Ramogola-Masire","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026091805314982700_ofag509-B26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/CEJ.0000000000000802","article-title":"Screening approaches for cervical cancer in Mozambique in HIV positive and negative women","volume":"32","author":"Sineque","year":"2023","journal-title":"Eur J Cancer Prev"},{"key":"2026091805314982700_ofag509-B27","article-title":"Prevalence and predictors of precancerous cervical lesions among women living with HIV in Libreville, Gabon","volume":"1","author":"Ambounda-Ledaga","year":"2024","journal-title":"Discov Med (Singap)"},{"key":"2026091805314982700_ofag509-B28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijid.2021.07.059","article-title":"Influence of HIV infection on the distribution of high-risk HPV types among women with cervical precancerous lesions in Yaounde, Cameroon","volume":"110","author":"Tagne Simo","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2026091805314982700_ofag509-B29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1086\/376996","article-title":"Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections","volume":"188","author":"Hawes","year":"2003","journal-title":"J Infect Dis"},{"key":"2026091805314982700_ofag509-B30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/14787210.2017.1392854","article-title":"Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV)","volume":"15","author":"Poljak","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026091805314982700_ofag509-B31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.46234\/ccdcw2020.092","article-title":"Detection and associated factors for cervical precancerous lesions among HIV-positive women from high HIV-burden areas\u2014China, 2015\u20132016","volume":"2","author":"Qiao","year":"2020","journal-title":"China CDC Wkly"},{"key":"2026091805314982700_ofag509-B32","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-024-03174-0","article-title":"Prevalence and risk factors associated with precancerous and cancerous cervical lesions among HIV-infected women in University of Gondar specialized comprehensive referral hospital, Northwest Ethiopia: cross-sectional study design","volume":"24","author":"Worku","year":"2024","journal-title":"BMC Women's Health"},{"key":"2026091805314982700_ofag509-B33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biopha.2014.12.041","article-title":"Overview of high-risk HPV's 16 and 18 infected cervical cancer: pathogenesis to prevention","volume":"70","author":"Ramakrishnan","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"2026091805314982700_ofag509-B34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.gore.2017.07.009","article-title":"Cervical cancer control in HIV-infected women: past, present and future","volume":"21","author":"Ghebre","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"2026091805314982700_ofag509-B35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ijc.28666","article-title":"Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort","volume":"135","author":"Roura","year":"2014","journal-title":"Int J Cancer"},{"key":"2026091805314982700_ofag509-B36","article-title":"Factors influencing cervical cancer screening practice among female health workers in Nigeria: a systematic review","volume":"5","author":"Okolie","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"2026091805314982700_ofag509-B37","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2022.41.276.21972","article-title":"Prevalence and risk factors associated with precancerous cervical lesions among women in two cities in Cameroon","volume":"41","author":"Wabo","year":"2022","journal-title":"Pan Afr Med J"},{"key":"2026091805314982700_ofag509-B38","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"2026091805314982700_ofag509-B39","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","article-title":"Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case\u2013control study","volume":"359","author":"Munoz","year":"2002","journal-title":"Lancet"},{"key":"2026091805314982700_ofag509-B40","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu","year":"2018","journal-title":"AIDS"},{"key":"2026091805314982700_ofag509-B41","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/infdis\/jit090","article-title":"Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women","volume":"207","author":"Konopnicki","year":"2013","journal-title":"J Infect Dis"},{"key":"2026091805314982700_ofag509-B42","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3257939","article-title":"Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination-review of current perspectives","volume":"2019","author":"Chan","year":"2019","journal-title":"J Oncol"},{"key":"2026091805314982700_ofag509-B43","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/498048","article-title":"Cervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa","volume":"2014","author":"Adler","year":"2014","journal-title":"Infect Dis Obstet Gynecol"},{"key":"2026091805314982700_ofag509-B44","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/omi.2018.0075","article-title":"Genetic susceptibility for cervical cancer in African populations: what are the host genetic drivers?","volume":"22","author":"Kuguyo","year":"2018","journal-title":"Omics"},{"key":"2026091805314982700_ofag509-B45","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cid\/cix135","article-title":"Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer","volume":"64","author":"Clifford","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026091805314982700_ofag509-B46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"2026091805314982700_ofag509-B47","first-page":"1","article-title":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Biological agents","volume":"100","author":"IARC Working Group","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"2026091805314982700_ofag509-B48","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-015-0015-z","article-title":"Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study","volume":"10","author":"Ali-Risasi","year":"2015","journal-title":"Infect Agent Cancer"},{"key":"2026091805314982700_ofag509-B49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/QAD.0000000000003437","article-title":"High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa","volume":"37","author":"Chachage","year":"2023","journal-title":"AIDS"},{"key":"2026091805314982700_ofag509-B50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212516","article-title":"Prevalence and distribution of human papillomavirus (HPV) genotypes among HIV infected women in Lom\u00e9, Togo","volume":"14","author":"Nyasenu","year":"2019","journal-title":"PLoS One"},{"key":"2026091805314982700_ofag509-B51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000325079","article-title":"Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa","volume":"53","author":"Firnhaber","year":"2009","journal-title":"Acta Cytol"},{"key":"2026091805314982700_ofag509-B52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s13337-019-00527-4","article-title":"Human papillomavirus in Ethiopia","volume":"30","author":"Derbie","year":"2019","journal-title":"Virusdisease"},{"key":"2026091805314982700_ofag509-B53","article-title":"Multiple anogenital cancers in a 26-year-old female: a case report","volume":"1","author":"Lee","year":"2023","journal-title":"SciBase Obstetr Gynecol"},{"key":"2026091805314982700_ofag509-B54","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2023.200262","article-title":"Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology","volume":"15","author":"Grover","year":"2023","journal-title":"Tumour Virus Res"},{"key":"2026091805314982700_ofag509-B55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/QCO.0000000000000805","article-title":"Progress and challenges in human papillomavirus and cervical cancer in southern Africa","volume":"35","author":"Ramogola-Masire","year":"2022","journal-title":"Curr Opin Infect Dis"},{"key":"2026091805314982700_ofag509-B56","author":"World Health Organization"},{"key":"2026091805314982700_ofag509-B57","author":"CDC"},{"key":"2026091805314982700_ofag509-B58","author":"World Health Organization"},{"key":"2026091805314982700_ofag509-B59","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2239085","article-title":"Human papillomavirus vaccine effectiveness by age at vaccination: a systematic review","volume":"19","author":"Ellingson","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"2026091805314982700_ofag509-B60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290808","article-title":"The clinical effectiveness of one-dose vaccination with an HPV vaccine: a meta-analysis of 902,368 vaccinated women","volume":"19","author":"Setiawan","year":"2024","journal-title":"PLoS One"},{"key":"2026091805314982700_ofag509-B61","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S1470-2045(21)00453-8","article-title":"Vaccine efficacy against persistent human papillomavirus (HPV) 16\/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study","volume":"22","author":"Basu","year":"2021","journal-title":"Lancet Oncol"},{"key":"2026091805314982700_ofag509-B62","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/jncimonographs\/lgae032","article-title":"HPV16\/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial","volume":"1","author":"Porras","year":"2024","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2026091805314982700_ofag509-B63","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1016\/S2214-109X(22)00309-6","article-title":"Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial","volume":"10","author":"Watson-Jones","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026091805314982700_ofag509-B64","author":"World Health Organization"},{"key":"2026091805314982700_ofag509-B65","doi-asserted-by":"crossref","first-page":"e1485","DOI":"10.1016\/S2214-109X(22)00306-0","article-title":"Comparing one dose of HPV vaccine in girls aged 9\u201314 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial","volume":"10","author":"Baisley","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026091805314982700_ofag509-B66","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100056","article-title":"Efficacy of single-dose HPV vaccination among young African women","volume":"1","author":"Barnabas","year":"2022","journal-title":"NEJM Evid"},{"key":"2026091805314982700_ofag509-B67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ijgo.14713","article-title":"The shift to one-dose HPV vaccination: where does this leave women living with HIV?","volume":"162","author":"McClymont","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"2026091805314982700_ofag509-B68","article-title":"Safety and immunogenicity of the nonavalent human papillomavirus vaccine in women living with HIV","volume":"12","author":"Moya","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"2026091805314982700_ofag509-B69","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101585","article-title":"Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: a systematic review and meta-analysis","volume":"52","author":"Staadegaard","year":"2022","journal-title":"eClinicalMedicine"},{"key":"2026091805314982700_ofag509-B70","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737","article-title":"The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?","volume":"23","author":"Patel","year":"2018","journal-title":"Euro Surveill"},{"key":"2026091805314982700_ofag509-B71","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"2026091805314982700_ofag509-B72","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"2026091805314982700_ofag509-B73","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1537250","article-title":"Human papillomavirus vaccine uptake and its determinants among women in Africa: an umbrella review","volume":"13","author":"Mengistie","year":"2025","journal-title":"Front Public Health"},{"key":"2026091805314982700_ofag509-B74","doi-asserted-by":"crossref","first-page":"e2006","DOI":"10.1016\/S2214-109X(25)00349-3","article-title":"Scaling HPV vaccination in Africa to eliminate cervical cancer by 2030","volume":"13","author":"Amani","year":"2025","journal-title":"Lancet Glob Health"},{"key":"2026091805314982700_ofag509-B75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106335","article-title":"National implementation of HPV vaccination programs in low-resource countries: lessons, challenges, and future prospects","volume":"144","author":"Tsu","year":"2021","journal-title":"Prev Med"},{"key":"2026091805314982700_ofag509-B76","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/j.vaccine.2021.04.025","article-title":"National introduction of human papillomavirus (HPV) vaccine in Tanzania: programmatic decision-making and implementation","volume":"40","author":"Mphuru","year":"2022","journal-title":"Vaccine"},{"key":"2026091805314982700_ofag509-B77","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1016\/j.vaccine.2023.04.072","article-title":"HPV vaccination acceptance and perceptions related to fertility and population control in the Gambia: an anthropological analysis","volume":"41","author":"Wilson","year":"2023","journal-title":"Vaccine"},{"key":"2026091805314982700_ofag509-B78","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-023-15842-1","article-title":"Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review","volume":"23","author":"Kutz","year":"2023","journal-title":"BMC Public Health"},{"key":"2026091805314982700_ofag509-B79","first-page":"85","article-title":"Attitude and perceived barriers to uptake of human papillomavirus vaccine among female students in a Nigerian tertiary institution","volume":"8","author":"Ihudiebube","year":"2019","journal-title":"Int J Med Res Health Sci"},{"key":"2026091805314982700_ofag509-B80","doi-asserted-by":"crossref","first-page":"A89","DOI":"10.1136\/ijgc-2019-IGCS.203","article-title":"203 Knowledge and awareness of HPV and HPV vaccine among HIV positive women in Lagos, Nigeria","volume":"29","author":"Sajo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"2026091805314982700_ofag509-B81","article-title":"A scoping review: facilitators and barriers of cervical cancer screening and early diagnosis of breast cancer in Sub-Saharan African health settings","volume":"33","author":"Pierz","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"2026091805314982700_ofag509-B82","author":"WHO"},{"key":"2026091805314982700_ofag509-B83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181156","article-title":"Integrating cervical cancer with HIV healthcare services: a systematic review","volume":"12","author":"Sigfrid","year":"2017","journal-title":"PLoS One"},{"key":"2026091805314982700_ofag509-B84","author":"PAHO"},{"key":"2026091805314982700_ofag509-B85","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ijc.29458","article-title":"Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India","volume":"137","author":"Basu","year":"2015","journal-title":"Int J Cancer"},{"key":"2026091805314982700_ofag509-B86","doi-asserted-by":"crossref","first-page":"87","DOI":"10.9745\/GHSP-D-15-00325","article-title":"The single-visit approach as a cervical cancer prevention strategy among women with HIV in Ethiopia: successes and lessons learned","volume":"4","author":"Shiferaw","year":"2016","journal-title":"Glob Health Sci Pract"},{"key":"2026091805314982700_ofag509-B87","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/IJWH.S10724","article-title":"Cervical cancer screening: knowledge, health perception and attendance rate among Hong Kong Chinese women","volume":"2","author":"Leung","year":"2010","journal-title":"Int J Womens Health"},{"key":"2026091805314982700_ofag509-B88","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.puhe.2021.04.014","article-title":"Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"Jun","author":"Yimer","year":"2021","journal-title":"Public Health"},{"key":"2026091805314982700_ofag509-B89","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/ijgc-00009577-200311000-00014","article-title":"Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya","volume":"13","author":"Gichangi","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"2026091805314982700_ofag509-B90","first-page":"59","article-title":"Clinic visits and cervical cancer screening in Accra","volume":"44","author":"Adanu","year":"2010","journal-title":"Ghana Med J"},{"key":"2026091805314982700_ofag509-B91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181415","article-title":"Knowledge, attitude and practice for cervical cancer prevention and control among women of childbearing age in Hossana Town, Hadiya zone, Southern Ethiopia: community-based cross-sectional study","volume":"12","author":"Aweke","year":"2017","journal-title":"PLoS One"},{"key":"2026091805314982700_ofag509-B92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.gore.2017.01.009","article-title":"Cervical cancer screening and treatment in Uganda","volume":"20","author":"Nakisige","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"2026091805314982700_ofag509-B93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149696","article-title":"Uptake of cervical cancer screening and associated factors among women in rural Uganda: a cross sectional study","volume":"11","author":"Ndejjo","year":"2016","journal-title":"PLoS One"},{"key":"2026091805314982700_ofag509-B94","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijgo.2015.07.038","article-title":"World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2\u20133 and screen-and-treat strategies to prevent cervical cancer","volume":"132","author":"Santesso","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"2026091805314982700_ofag509-B95","doi-asserted-by":"crossref","DOI":"10.1093\/heapro\/daae042","article-title":"Evaluation of cancer screening services provided for people living with HIV in Botswana, 2022\u20132023","volume":"39","author":"Mathoma","year":"2024","journal-title":"Health Promot Int"},{"key":"2026091805314982700_ofag509-B96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050132","article-title":"Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities","volume":"5","author":"Gakidou","year":"2008","journal-title":"PLoS Med"},{"key":"2026091805314982700_ofag509-B97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106900","article-title":"Worldwide use of HPV self-sampling for cervical cancer screening","volume":"154","author":"Serrano","year":"2022","journal-title":"Prev Med"},{"key":"2026091805314982700_ofag509-B98","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijgo.13112","article-title":"A systematic review of self-sampling for HPV testing in Africa","volume":"149","author":"Nodjikouambaye","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"2026091805314982700_ofag509-B99","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-025-04504-1","article-title":"Role of prior HPV infection and CD4 T-cell count in modulating cellular immune responses to a three-dose nonavalent HPV vaccine schedule in PWH receiving ART","volume":"23","author":"Tortellini","year":"2025","journal-title":"BMC Med"},{"key":"2026091805314982700_ofag509-B100","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1016\/j.vaccine.2016.08.016","article-title":"HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine","volume":"34","author":"Money","year":"2016","journal-title":"Vaccine"},{"key":"2026091805314982700_ofag509-B101","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","article-title":"Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis","volume":"5","author":"Kelly","year":"2018","journal-title":"Lancet HIV"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/9\/ofag509\/70952230\/ofag509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/9\/ofag509\/70952230\/ofag509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:32:38Z","timestamp":1789723958000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag509\/8785337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag509","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"ofag509"}}